Aggreguide A-100 ADP Assay Evaluation
Completed
Conditions studied: Platelet Aggregation, ADP Blockers
In brief
The study is to characterize the AggreGuide ADP Assay's performance.
Key facts
- Study ID
- NCT02112539
- Run by
- Aggredyne, Inc.
- People needed
- 150
- Starts
- 2014-03-01
- Expected to finish
- 2014-08-01
- Last updated by the study team
- 2017-04-04
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 18-75
You may not qualify if…
- less than 60 kg
- on antiplatelet meds other than aspirin
- antiplatelet drugs contraindicated
Where it is running
- Juno Research — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.